Learn More
Medchemexpress LLC Benzyl N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]carbamate | 26049-94-5 | MFCD00037114 | 99.0% | 331.79 g·mol⁻1 | C18H18ClNO3 | 250 MG

Supplier: Medchemexpress LLC HY100709250MG
ZPCK is an orally active prodrug of gemcitabine developed to improve oral bioavailability for preclinical research. It functions as an autophagy inducer and is used in studies of nucleoside antimetabolite pharmacology, drug delivery, and oral formulation evaluation. For research use only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.